The Lancet

The Lancet

Publication
0 followers

Leading medical journal with videos on clinical research, global health, and technology-enabled care and diagnostics discussion.

What Is in a Name Change? Moving From the Term PCOS to PMOS
VideoMay 26, 2026

What Is in a Name Change? Moving From the Term PCOS to PMOS

The Lancet Pulse episode discusses the landmark decision to rename polycystic ovarian syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS). The change reflects a growing scientific consensus that the condition is fundamentally an endocrine and metabolic disorder, not a...

By The Lancet
Is There a Link Between Diet and Mental Health?
VideoMay 18, 2026

Is There a Link Between Diet and Mental Health?

The Lancet podcast explores whether a ketogenic diet can influence mental health, focusing on its emerging role in managing bipolar disorder. Host Niall Boyce and guest Daniel "Danny" Smith discuss the diet’s composition—high fat, low carbohydrate—and its historical use for...

By The Lancet
[Comment] Life at the Water's Edge: A Lancet Commission on Sea-Level Rise, Health, and Justice
NewsApr 7, 2026

[Comment] Life at the Water's Edge: A Lancet Commission on Sea-Level Rise, Health, and Justice

The Lancet Commission’s latest comment warns that accelerating sea‑level rise will reshape daily life for hundreds of millions, with up to 410 million people projected to live below the high‑tide line by 2100. It details how rising waters amplify disease transmission,...

By The Lancet
[Correspondence] Suicidal Crisis: First Regulatory Approval of IV Racemic Ketamine
NewsApr 3, 2026

[Correspondence] Suicidal Crisis: First Regulatory Approval of IV Racemic Ketamine

In March 2026 France became the first country to grant regulatory approval for intravenous racemic ketamine as a treatment for adult severe suicidal crisis. Clinical trials have shown that a single 0.5 mg/kg infusion over 40 minutes can blunt suicidal ideation...

By The Lancet
[Correspondence] War Economies and Collapsing Health Systems
NewsApr 3, 2026

[Correspondence] War Economies and Collapsing Health Systems

Rising defence budgets are crowding out public health financing, with a 1 % increase in military spending cutting health budgets by 0.62 % globally and 0.96 % in low‑income nations. Conflict‑related destruction, supply‑chain blockades and sanctions have already caused tens of millions of...

By The Lancet
[Correspondence] Cancer, Climate Change, Fossil Fuels, and War: A Call for Action
NewsApr 3, 2026

[Correspondence] Cancer, Climate Change, Fossil Fuels, and War: A Call for Action

Nancy Krieger’s correspondence highlights a growing body of research linking climate change to cancer, while exposing a glaring gap in accountability for fossil‑fuel‑driven wars. The article cites recent studies on pollution, occupational exposures, and climate refugees, and draws attention to...

By The Lancet
[Correspondence] Sound Mind, Sound Place: Ibasho and Post-Disaster Mental Health
NewsApr 3, 2026

[Correspondence] Sound Mind, Sound Place: Ibasho and Post-Disaster Mental Health

The correspondence argues that post‑disaster mental health must move beyond acute symptom checklists toward community‑based recovery, highlighting Japan’s *ibasho*—a locally‑led place that embeds individuals in social networks and meaningful roles. Data from the 2011 Great East Japan Earthquake show that...

By The Lancet
[Comment] Targeted Advertising in Generative Artificial Intelligence Chatbots: A New Public Health Risk
NewsApr 2, 2026

[Comment] Targeted Advertising in Generative Artificial Intelligence Chatbots: A New Public Health Risk

OpenAI announced it will embed targeted advertising in the free and low‑cost versions of ChatGPT, pairing the rollout with safeguards such as ad‑response separation, privacy protections, age gating for users under 18, and limits on health‑related ads. The move addresses...

By The Lancet
[Comment] Rethinking Country Classifications Towards a More Equitable Global Health Future
NewsApr 2, 2026

[Comment] Rethinking Country Classifications Towards a More Equitable Global Health Future

The authors argue that the World Bank’s income‑based country classification, which groups nations into low, middle and high income based on gross national income per capita, no longer reflects health system realities. They show that income alone masks profound heterogeneity...

By The Lancet
[Articles] Deferral of Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation (PRO-TAVI): An Investigator-Initiated, Multicentre, Open-Label, Non-Inferiority, Randomised...
NewsMar 29, 2026

[Articles] Deferral of Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation (PRO-TAVI): An Investigator-Initiated, Multicentre, Open-Label, Non-Inferiority, Randomised...

The PRO‑TAVI investigator‑initiated trial randomised 466 patients with coronary artery disease undergoing transcatheter aortic valve implantation to either deferred percutaneous coronary intervention (PCI) or PCI before TAVI. At one year, the composite of all‑cause mortality, myocardial infarction, stroke and major...

By The Lancet
[Comment] Coronary Revascularisation Before TAVI
NewsMar 29, 2026

[Comment] Coronary Revascularisation Before TAVI

Coronary artery disease affects up to half of patients referred for transcatheter aortic valve implantation (TAVI), raising the question of whether routine percutaneous coronary intervention (PCI) before valve replacement improves outcomes. The PRO‑TAVI trial, a multicenter non‑inferiority randomized study, compared...

By The Lancet
[Articles] Aspirin versus Clopidogrel for Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention: 10-Year Follow-Up of the HOST-EXAM Trial
NewsMar 29, 2026

[Articles] Aspirin versus Clopidogrel for Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention: 10-Year Follow-Up of the HOST-EXAM Trial

Ten‑year extended follow‑up of the HOST‑EXAM trial compared clopidogrel 75 mg daily with aspirin 100 mg daily as chronic monotherapy after PCI. Among 5,438 patients, clopidogrel achieved a 25.4% incidence of the composite of death, MI, stroke, ACS readmission, or major bleeding...

By The Lancet
[Comment] Moving Beyond Aspirin After Percutaneous Coronary Intervention: 10-Year Results From the HOST-EXAM Trial
NewsMar 29, 2026

[Comment] Moving Beyond Aspirin After Percutaneous Coronary Intervention: 10-Year Results From the HOST-EXAM Trial

The HOST-EXAM trial, with ten-year follow‑up, compared clopidogrel monotherapy to aspirin after percutaneous coronary intervention. Results showed clopidogrel achieved lower rates of major adverse cardiovascular events and major bleeding. The study enrolled over 5,000 patients from diverse centers, reinforcing the...

By The Lancet
[Therapeutics] Pyruvate Kinase Activators in Hereditary Haemolytic Anaemias: Current Evidence and Clinical Potential
NewsMar 12, 2026

[Therapeutics] Pyruvate Kinase Activators in Hereditary Haemolytic Anaemias: Current Evidence and Clinical Potential

Hereditary hemolytic anemias affect millions worldwide and have few disease‑modifying options. Oral pyruvate kinase activators, especially mitapivat, increase glycolytic ATP production, correcting a common metabolic defect in red cells. Clinical trials have shown efficacy in pyruvate kinase deficiency, sickle cell...

By The Lancet
The Lancet | Pulse